Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease

Rasmus Sejersten Ripa, Yongzhong Wang, Erik Jørgensen, Hans Erik Johnsen, Birger Hesse, Jens Kastrup

115 Citations (Scopus)

Abstract

To assess the safety and effects of combined treatment with vascular endothelial growth factor-A(165) plasmid (VEGF-A(165)) and granulocyte- colony stimulating factor (G-CSF) mobilization of bone marrow stem cells in patients with severe chronic ischaemic heart disease (IHD).
Original languageEnglish
JournalEuropean Heart Journal
Volume27
Issue number15
Pages (from-to)1785-92
Number of pages8
ISSN0195-668X
DOIs
Publication statusPublished - Aug 2006
Externally publishedYes

Keywords

  • Adolescent
  • Adult
  • Aged
  • Chronic Disease
  • Coronary Circulation
  • Drug Therapy, Combination
  • Female
  • Granulocyte Colony-Stimulating Factor
  • Hematopoietic Stem Cell Mobilization
  • Humans
  • Injections, Intralesional
  • Magnetic Resonance Angiography
  • Male
  • Middle Aged
  • Myocardial Ischemia
  • Neovascularization, Physiologic
  • Prospective Studies
  • Recombinant Proteins
  • Tomography, Emission-Computed, Single-Photon
  • Treatment Outcome
  • Vascular Endothelial Growth Factor A

Fingerprint

Dive into the research topics of 'Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease'. Together they form a unique fingerprint.

Cite this